Postmastectomy Radiotherapy
Publication Date: December 1, 2016
Last Updated: March 14, 2022
Recommendations
PMRT for patients With T1-2 tumors with one to three positive axillary lymph nodes who undergo ALND
The panel unanimously agreed that the available evidence shows that PMRT reduces the risks of LRF, any recurrence, and breast cancer mortality for patients with T1-2 breast cancer with one to three positive axillary nodes. (EB, H, S)
615
Title
Postmastectomy Radiotherapy
Authoring Organizations
American Society for Radiation Oncology
American Society of Clinical Oncology
Society of Surgical Oncology